BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Egere U, Sillah A, Togun T, Kandeh S, Cole F, Jallow A, Able-Thomas A, Hoelscher M, Heinrich N, Hill PC, Kampmann B. Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. Public Health Action 2016;6:226-31. [PMID: 28123958 DOI: 10.5588/pha.16.0073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Birungi FM, Graham S, Uwimana J, van Wyk B. Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study. Tuberc Res Treat 2018;2018:8690714. [PMID: 29854455 DOI: 10.1155/2018/8690714] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Kendall EA, Durovni B, Martinson NA, Cavalacante S, Masonoke K, Saraceni V, Lebina L, Efron A, Cohn S, Chon S, Chaisson RE, Dowdy DW, Golub JE; THRio and TEKO teams. Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. AIDS 2020;34:63-71. [PMID: 31567163 DOI: 10.1097/QAD.0000000000002380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Emerson C, Ng'eno B, Ngowi B, Pals S, Kohi W, Godwin M, Date A, Modi S. Assessment of routine screening of pediatric contacts of adults with tuberculosis disease in Tanzania. Public Health Action 2019;9:148-52. [PMID: 32042606 DOI: 10.5588/pha.19.0034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Otero L, Battaglioli T, Ríos J, De la Torre Z, Trocones N, Ordoñez C, Seas C, Van der Stuyft P. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. Trop Med Int Health 2020;25:346-56. [PMID: 31758837 DOI: 10.1111/tmi.13350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Grace SG. Barriers to the implementation of isoniazid preventive therapy for tuberculosis in children in endemic settings: A review. J Paediatr Child Health 2019;55:278-84. [PMID: 30604557 DOI: 10.1111/jpc.14359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis 2019;19:e96-e108. [PMID: 30322790 DOI: 10.1016/S1473-3099(18)30157-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 10.7] [Reference Citation Analysis]
7 Busari AA, Oshikoya KA, Adejumo IA, Olanrewaju OA, Usman SO, Badru WA, Oreagba IA, Olayemi SO. Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria. Pan Afr Med J 2021;39:123. [PMID: 34527139 DOI: 10.11604/pamj.2021.39.123.28095] [Reference Citation Analysis]
8 Basu Roy R, Sambou B, Sissoko M, Holder B, Gomez MP, Egere U, Sillah AK, Koukounari A, Kampmann B. Protection against mycobacterial infection: A case-control study of mycobacterial immune responses in pairs of Gambian children with discordant infection status despite matched TB exposure. EBioMedicine 2020;59:102891. [PMID: 32675024 DOI: 10.1016/j.ebiom.2020.102891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 LaCourse SM, Leon D, Panpradist N, Richardson BA, Maleche-Obimbo E, Mecha J, Matemo D, Escudero JN, Kinuthia J, Lutz B, John-Stewart G. Urine Biomarker Assessment of Infant Adherence to Isoniazid Prophylaxis. Pediatr Infect Dis J 2021;40:e43-5. [PMID: 33055504 DOI: 10.1097/INF.0000000000002936] [Reference Citation Analysis]
10 Basu Roy R, Sambou B, Uhía I, Roetynck S, Robertson BD, Kampmann B. An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes. Front Pediatr 2019;7:151. [PMID: 31114771 DOI: 10.3389/fped.2019.00151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Seid G, Tsedalu T, Ayele M. Adherence to Isoniazid Preventive Therapy among Under-Five Children in Contact with Adult Bacteriologically Confirmed Pulmonary Tuberculosis Patients: A Mixed-Method Study. Int J Microbiol 2020;2020:8834806. [PMID: 33061981 DOI: 10.1155/2020/8834806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Togun T, Hoggart CJ, Agbla SC, Gomez MP, Egere U, Sillah AK, Saidy B, Mendy F, Pai M, Kampmann B. A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children. EBioMedicine 2020;58:102909. [PMID: 32711253 DOI: 10.1016/j.ebiom.2020.102909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS One 2017;12:e0182185. [PMID: 28763500 DOI: 10.1371/journal.pone.0182185] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
14 Owolabi OA, Jallow AO, Jallow M, Sowe G, Jallow R, Genekah MD, Donkor S, Wurrie A, Kampmann B, Sutherland J, Togun T. Delay in the diagnosis of pulmonary tuberculosis in The Gambia, West Africa: A cross-sectional study. Int J Infect Dis 2020;101:102-6. [PMID: 32949776 DOI: 10.1016/j.ijid.2020.09.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]